肿瘤的基因-放射治疗是近年来发展起来的新技术.分别于体外和体内检测含辐射敏感启动子和mIL-12基因的真核表达载体(pNEgr-mIL-12)的生物学活性.体外经酶联免疫吸附试验(enzyme linked immunosorbent assay, ELISA)法检测转染pNEgr-mIL-12重组质粒的COS-7和B16细胞可经辐射诱导mIL-12 p70表达,于1.5~2.0 Gy照射后表达增高最明显,COS-7细胞于照后4 h 达峰值,B16细胞的表达水平随照射后时间延长而逐渐增高;pNEgr-mIL-12重组质粒联合电离辐射治疗小鼠移植肿瘤,单次或多次注射pNEgr-mIL-12重组质粒,联合局部照射能够抑制小鼠移植肿瘤生长,与单纯照射组比较肿瘤生长速度减慢,瘤重降低,尤以多次给予质粒治疗组效果明显.为进一步探讨最佳治疗方案及临床肿瘤病人的基因放射治疗提供了初步依据.
The expression of mIL-12 p70 in the supernatant of cultured COS-7 and B16 melanoma cells transfected with pNEgr-mIL-12 and the tumor growth rate in mice after gene-radiotherapy with pNEgr-mIL-12 plasmid and different doses X-irradiation were observed. The expression of mIL-12 p70 in the supernatant of COS-7 and B16 melanoma cells were most prominent after X-irradiation with 1.5~2.0 Gy, and doses as low as 0.05 Gy also showed a stimulatory effect. Time-course studies showed that the expression of mIL-12 p70 in the supernatant of COS-7 cells reached its peak at 4 h after irradiation and a progressive increase in expression of mIL-12 p70 in the supernatant of B16 melanoma cells was observed over the study period of 72 h. In vivo, the injection of pNE-mIL12 recombinat plasmid into tumor followed by local X-irradiation one or three times could inhibit the growth of B16 melanoma implanted in C57BL/6J mice and the surviving days of tumor-bearing mice was delayed. It will provide an experimental basis for planning effective clinical gene-radiotherapy of cancer.
杨英,刘树铮,付士波. pNEgr-mIL-12真核表达载体的体外和体内生物学活性检测[J].生物化学与生物物理进展,2002,29(5):790-795
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号